A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
Clinical trial NCT05578976 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05578976
- Sponsor
- Genmab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-08
- Primary completion
- 2027-06-01
- Enrollment
- 900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.